SYNAPTICS Inc Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAPTICS Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SYNAPTICS Inc for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 16 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 128.89 | 1,700 | 219,113 | 37,045 | 38.7 K to 37 K (-4.39 %) |
Feb 16 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 125.00 | 1,769 | 221,125 | 38,745 | 40.5 K to 38.7 K (-4.37 %) |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 52.57 | 2,900 | 152,453 | 0 | |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 125.00 | 2,900 | 362,500 | 34,210 | 37.1 K to 34.2 K (-7.81 %) |
Feb 12 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 52.57 | 2,900 | 152,453 | 37,110 | 34.2 K to 37.1 K (+8.48 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.77 | 3,575 | 195,803 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.36 | 3,575 | 194,337 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 52.57 | 3,575 | 187,938 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 51.95 | 2,725 | 141,564 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 71.55 | 2,725 | 194,974 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 73.31 | 2,725 | 199,770 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 85.69 | 3,000 | 257,070 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 76.81 | 3,000 | 230,430 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 89.29 | 2,725 | 243,315 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 79.38 | 3,000 | 238,140 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 123.02 | 7,722 | 949,934 | 14,860 | 22.6 K to 14.9 K (-34.20 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 122.59 | 4,328 | 530,574 | 22,582 | 26.9 K to 22.6 K (-16.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.41 | 1,400 | 169,971 | 26,910 | 28.3 K to 26.9 K (-4.95 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.77 | 3,575 | 195,803 | 28,310 | 24.7 K to 28.3 K (+14.45 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.36 | 3,575 | 194,337 | 24,735 | 21.2 K to 24.7 K (+16.90 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 52.57 | 3,575 | 187,938 | 21,160 | 17.6 K to 21.2 K (+20.33 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 51.95 | 2,725 | 141,564 | 17,585 | 14.9 K to 17.6 K (+18.34 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.47 | 4,211 | 511,496 | 14,860 | 19.1 K to 14.9 K (-22.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 120.43 | 1,674 | 201,606 | 19,071 | 20.7 K to 19.1 K (-8.07 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 118.66 | 8,190 | 971,826 | 20,745 | 28.9 K to 20.7 K (-28.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 117.47 | 3,100 | 364,154 | 28,935 | 32 K to 28.9 K (-9.68 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 71.55 | 2,725 | 194,974 | 32,035 | 29.3 K to 32 K (+9.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 73.31 | 2,725 | 199,770 | 29,310 | 26.6 K to 29.3 K (+10.25 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 85.69 | 3,000 | 257,070 | 26,585 | 23.6 K to 26.6 K (+12.72 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 76.81 | 3,000 | 230,430 | 23,585 | 20.6 K to 23.6 K (+14.57 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 89.29 | 2,725 | 243,315 | 20,585 | 17.9 K to 20.6 K (+15.26 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 79.38 | 3,000 | 238,140 | 17,860 | 14.9 K to 17.9 K (+20.19 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 119.92 | 567 | 67,995 | 23,229 | 23.8 K to 23.2 K (-2.38 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 118.45 | 3,433 | 406,628 | 23,796 | 27.2 K to 23.8 K (-12.61 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Sell | S | 117.48 | 4,400 | 516,913 | 27,229 | 31.6 K to 27.2 K (-13.91 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | WHIMS JAMES L | Director | Buy | M | 62.11 | 2,400 | 149,052 | 31,629 | 29.2 K to 31.6 K (+8.21 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 89.29 | 2,302 | 205,546 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 123.00 | 2,302 | 283,146 | 34,210 | 36.5 K to 34.2 K (-6.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Sell | S | 120.18 | 2,400 | 288,427 | 36,512 | 38.9 K to 36.5 K (-6.17 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 89.29 | 2,302 | 205,546 | 38,912 | 36.6 K to 38.9 K (+6.29 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | CHAN NELSON C | Director | Buy | M | 62.11 | 2,400 | 149,052 | 36,610 | 34.2 K to 36.6 K (+7.02 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Option Exercise | M | 62.11 | 2,400 | 149,052 | 0 | |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Sell | S | 119.92 | 2,400 | 287,808 | 10,148 | 12.5 K to 10.1 K (-19.13 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | BUCHANAN JEFFREY D | Director | Buy | M | 62.11 | 2,400 | 149,052 | 12,548 | 10.1 K to 12.5 K (+23.65 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 122.00 | 1,294 | 157,868 | 40,514 | 41.8 K to 40.5 K (-3.10 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Awsare Saleel | See Remarks | Sell | S | 122.04 | 500 | 61,020 | 41,808 | 42.3 K to 41.8 K (-1.18 %) |
Feb 09 2021 | SYNA | SYNAPTICS Inc | Butler Dean Warren | See Remarks | Sell | S | 119.92 | 1,050 | 125,916 | 27,484 | 28.5 K to 27.5 K (-3.68 %) |
Feb 02 2021 | SYNA | SYNAPTICS Inc | NOLAN KERMIT | See Remarks | Payment of Exercise | F | 99.22 | 2,075 | 205,882 | 35,636 | 37.7 K to 35.6 K (-5.50 %) |